Hormone Health Hub: Expert Insights on Testing, Balance & Better Living — endocrine diagnostics UK

At-home hormone testing using saliva, dried blood spot and dried urine collection is not only more convenient than clinic-based blood draws — it is also safer, more accurate for certain hormones, and essential for capturing time-sensitive samples like waking cortisol or first-morning melatonin. This article explains how each collection method works, why dried samples carry minimal infection risk, and how ZRT Laboratory’s CLIA-certified processes ensure reliable results.

Thyroid cancer is now among the top 10 most common cancers worldwide, with incidence rising by an average of 5.5% per year. But experts are divided: is this a genuine epidemic, or an epidemic of diagnosis driven by more sensitive imaging? This article reviews the evidence on both sides, explores the role of iodine deficiency, radiation exposure and environmental factors, and explains why thyroid awareness — and monitoring — matters year-round.

Breast cancer is not one disease — it encompasses many distinct types with different attributes, degrees of invasiveness and treatment responses. Understanding the difference between invasive and non-invasive cancers, what hormone receptor status means, and which risk factors are modifiable can help women make more informed decisions about screening, lifestyle and hormone health. This article provides a clear, evidence-based overview.

Dr. Cobi Slater’s Ultimate Hormone Balancing Guidebook arrives at a moment when hormonal dysfunction has never been more widespread. Her central argument — that the real cause behind the plethora of symptoms plaguing modern adults can be linked to imbalances within the hormonal cascade — is backed by research-based evidence and practical, natural solutions. This review covers the book’s key chapters and explains why it remains an essential reference for anyone navigating hormone health.

When sex hormone test results show both oestradiol (E2) and progesterone (Pg) within normal ranges, yet symptoms persist, the Pg/E2 ratio provides a critical additional layer of clinical insight. A low ratio points to oestrogen dominance; a high ratio to progesterone dominance — each requiring a different therapeutic response. This article explains how the ratio is calculated, when it is clinically relevant, and how a real-world case illustrates its practical value.